Financial reports
Current reports
6-K
Current report (foreign)
25 Apr 24
6-K
Current report (foreign)
19 Apr 24
6-K
Current report (foreign)
16 Apr 24
6-K
Alvotech Announces Increase in Number of Own Shares
22 Mar 24
6-K
Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
20 Mar 24
6-K
Alvotech Appoints Interim Chief Quality Officer
1 Mar 24
6-K
Alvotech Accepts Offer for the Sale of Shares for a value of approximately USD 166 million at a Purchase price of USD 16.41 (ISK 2,250) per Share
26 Feb 24
6-K
Current report (foreign)
23 Feb 24
6-K
Current report (foreign)
15 Feb 24
6-K
Current report (foreign)
29 Jan 24
Registration and prospectus
F-3
Shelf registration (foreign)
20 Oct 23
424B3
Prospectus supplement
24 Jul 23
424B3
Prospectus supplement
24 Jul 23
F-3
Shelf registration (foreign)
14 Jul 23
POS AM
Prospectus update (post-effective amendment)
14 Jul 23
424B3
Prospectus supplement
29 Jun 23
424B3
Prospectus supplement
6 Jun 23
424B3
Prospectus supplement
24 May 23
424B3
Prospectus supplement
14 Apr 23
POS AM
Prospectus update (post-effective amendment)
13 Mar 23
Proxies
No filings
Other
EFFECT
Notice of effectiveness
31 Oct 23
CORRESP
Correspondence with SEC
27 Oct 23
UPLOAD
Letter from SEC
26 Oct 23
EFFECT
Notice of effectiveness
24 Jul 23
EFFECT
Notice of effectiveness
21 Jul 23
CORRESP
Correspondence with SEC
20 Jul 23
UPLOAD
Letter from SEC
20 Jul 23
EFFECT
Notice of effectiveness
17 Mar 23
EFFECT
Notice of effectiveness
22 Sep 22
EFFECT
Notice of effectiveness
22 Sep 22
Ownership
SC 13G/A
Oaktree Acquisition Holdings II, L.P.
14 Feb 24
SC 13G
Oaktree Acquisition Holdings II, L.P.
14 Feb 23
SC 13D/A
Celtic Holdings SCA
18 Nov 22
SC 13D/A
Aztiq Pharma Partners S.a r.l.
18 Jul 22
SC 13D/A
Celtic Holdings SCA
15 Jul 22
SC 13D
Aztiq Pharma Partners S.a r.l.
5 Jul 22
SC 13D
Celtic Holdings SCA
27 Jun 22
SC 13G
YA II PN, Ltd.
22 Jun 22